Evidence map›Paper›PMID 38892477›Full record

SynthesisNutrients2024

Effects of Hydrolyzed Collagen as a Dietary Supplement on Fibroblast Activation: A Systematic Review.

Pedro Augusto Querido Inacio, Felipe Augusto Chaluppe, Gerson Ferreira Aguiar, Carly de Faria Coelho, Rodolfo P Vieira

Registry-linked trialAbstract readSystematic Review
In one paragraph

Synthesis in Nutrients, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07516756 (Impact of Oral Supplementation of Specific Bioactive Collagen Peptides on Human Skin Physiology), which is not on this map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07516756 nacompletednot on this map

Impact of Oral Supplementation of Specific Bioactive Collagen Peptides on Human Skin Physiology: A Randomized, Double-Blind, Placebo-Controlled Trial

TypeinterventionalSponsorCollagen Research InstituteRan2024 to 2024Enrolled66ConditionsAge-related Changes in Skin Appearance and PhysiologyArmsPlacebo, Specific Collagen Peptides
3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Trial
  2. Article
  3. Operational Standard for Tissue-Extracted Collagen Facial Injection Techniques.Clinical, cosmetic and investigational dermatology · 2026
    Article
  4. Article
  5. Review
  6. Review
  7. Targeting collagen to optimize cancer immunotherapy.Experimental hematology & oncology · 2025
    Review
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Pedro Augusto Querido InacioLaboratory of Pulmonary and Exercise Immunology (LABPEI), Evangelical University of Goias (Unievangelica), Avenida Universitária Km 3.5, Anápolis 75083-515, GO, Brazil.ORCID 0000-0001-9354-1460
Felipe Augusto ChaluppePeptech Colagen from Brazil, 1500 North Halsted Street-Floor 2, Chicago, IL 60642-2517, USA.ORCID 0000-0002-9298-4056
Gerson Ferreira AguiarLaboratory of Pulmonary and Exercise Immunology (LABPEI), Evangelical University of Goias (Unievangelica), Avenida Universitária Km 3.5, Anápolis 75083-515, GO, Brazil.
Carly de Faria CoelhoLaboratory of Pulmonary and Exercise Immunology (LABPEI), Evangelical University of Goias (Unievangelica), Avenida Universitária Km 3.5, Anápolis 75083-515, GO, Brazil.ORCID 0009-0004-8651-6514
Rodolfo P VieiraLaboratory of Pulmonary and Exercise Immunology (LABPEI), Evangelical University of Goias (Unievangelica), Avenida Universitária Km 3.5, Anápolis 75083-515, GO, Brazil.ORCID 0000-0001-6379-1143

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOur objective was to conduct a systematic review of the effects of hydrolyzed collagen supplementation on the proliferation and activation of fibroblasts.

methodsThe search was conducted for journals that published articles in the English language, peer-reviewed, meeting the following criteria: (a) randomized clinical trials, (b) randomized studies in animals or humans, (c) in vitro studies, (d) studies using hydrolyzed collagens or collagen peptides, and (e) studies assessing alterations on fibroblasts as the primary or secondary outcome. We utilized the main journal databases PubMed/Web of Science and ongoing reviews by PROSPERO. For bias risk and methodological quality, we used an adaptation of the Downs and Black checklist. Our review followed the PRISMA checklist, conducted from February 2024 to the first week of March 2024, by two independent researchers (P.A.Q.I. and R.P.V.).

resultsEleven studies were included in this review, where our findings reinforce the notion that hydrolyzed collagens or collagen peptides at concentrations of 50-500 μg/mL are sufficient to stimulate fibroblasts in human and animal tissues without inducing toxicity. Different enzymatic processes may confer distinct biological properties to collagens, allowing for scenarios favoring fibroblast promotion or antioxidant effects. Lastly, collagens with lower molecular weights exhibit greater bioavailability to adjacent tissues.

conclusionsHydrolyzed collagens or collagen peptides with molecular sizes ranging from <3 to 3000 KDa promote the stimulation of fibroblasts in human tissues.

Indexed as

CollagenDietary SupplementsFibroblastsAnimalsCell ProliferationHumansHydrolysisCollagencollagen supplementationfibroblasthydrolyzed collagenlow-molecular-weight collagen peptides

Identifiers

PMID38892477
PMCPMC11173906

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.